T3011
Showing 51 - 75 of 203
Ulcerative Colitis Trial in Worldwide (Etrozulimab, Placebo)
Urinary Incontinence, Urgency Urinary Trial in Boston (Oxybutynin, Solifenacin, Tolterodine, Sanctura or Toviaz)
Completed
- Urinary Incontinence
- Urgency Urinary
- Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine
-
Boston, MassachusettsBrigham & Women's Hospital
Oct 21, 2022
Type 1 Diabetes Trial in Worldwide (rhIL-2, Placebo)
Active, not recruiting
- Type 1 Diabetes
- rhIL-2
- Placebo
-
Liège, Province De Liège, Belgium
- +33 more
Feb 9, 2022
Ulcerative Colitis Trial in Worldwide (Placebo, Guselkumab)
Active, not recruiting
- Ulcerative Colitis
- Placebo
- Guselkumab
-
Lancaster, California
- +390 more
Jan 17, 2023
Pain, Chronic, Opioid Dependence, Opioid Use Trial in New York (Root.Health Dietary Supplement)
Enrolling by invitation
- Pain, Chronic
- +3 more
- Root.Health Dietary Supplement
-
New York, New YorkHudson Medical
Jun 9, 2023
Type 1 Diabetes Trial in Worldwide (Teplizumab (MGA031), Placebo)
Completed
- Type 1 Diabetes Mellitus
- Teplizumab (MGA031)
- Placebo
-
Birmingham, Alabama
- +117 more
Feb 4, 2022
Hepatocellular Carcinoma Trial in Beijing (HAIC, TACE, FOLFOX)
Recruiting
- Hepatocellular Carcinoma
- HAIC
- +4 more
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jan 10, 2022
Patterns With Lucentis® in Real-life Conditions in All Approved
Completed
- Neovascular (Wet) Age-related Macular Degeneration
-
Ettlingen, Baden Wuerttemberg, Germany
- +174 more
Apr 12, 2021
Ulcerative Colitis (UC) Trial in Worldwide (risankizumab, for risankizumab)
Enrolling by invitation
- Ulcerative Colitis (UC)
- risankizumab
- placebo for risankizumab
-
Coronado, California
- +423 more
May 26, 2022
Neovascular Age-related Macular Degeneration Trial in Worldwide (0.5 mg Conbercept Intravitreal Injection, 1.0 mg Conbercept
Terminated
- Neovascular Age-related Macular Degeneration
- 0.5 mg Conbercept Intravitreal Injection
- +2 more
-
Phoenix, Arizona
- +178 more
Jun 23, 2021
The Next Generation Longitudinal Birth Cohort Diabetes Study
Recruiting
- Type 2 Diabetes
- Gestational Diabetes Mellitus
- Observational screening study
-
Winnipeg, Manitoba, CanadaChildren's Hospital Research Institute of Manitoba/University of
Nov 3, 2020
Ulcerative Colitis (UC) Trial in Worldwide (risankizumab IV, for risankizumab, risankizumab SC)
Recruiting
- Ulcerative Colitis (UC)
- risankizumab IV
- +2 more
-
Coronado, California
- +429 more
Aug 11, 2022
Pituitary Tumours: Prevalence of Associated Neoplasia
Recruiting
- Pituitary Tumor
- +4 more
- Registration of familial forms and associated neoplasia
-
Pozzilli, IS, ItalyNeuromed
Aug 31, 2021
NSCLC Stage III Trial in Paris, Milan, Barcelona (durvalumab plus platinum-based chemo (cisplatin or carboplatin plus
Recruiting
- Non-small Cell Lung Cancer Stage III
- durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed)
- +2 more
-
Paris, France
- +2 more
May 30, 2022
Laparoscopic Surgical Procedure, Nerve Block Trial in Stockholm (LAPTAP)
Recruiting
- Laparoscopic Surgical Procedure
- Nerve Block
- LAPTAP
-
Stockholm, SwedenDanderyd Hospital
Sep 27, 2021
Hepatocellular Carcinoma Trial in Toronto, Milan, Pamplona (Tremelimumab)
Not yet recruiting
- Hepatocellular Carcinoma
-
Toronto, Ontario, Canada
- +2 more
Jun 27, 2022
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +3 more
-
Birmingham, Alabama
- +229 more
Aug 11, 2022
Prostatic Tumors Trial in Worldwide (Enzalutamide, Conventional NSAA, LHRHA)
Active, not recruiting
- Prostatic Neoplasms
- Enzalutamide
- +3 more
-
Boston, Massachusetts
- +68 more
Apr 1, 2021